Search

everythinglearnresearchcommunity

for

Search:↓

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Flightless I protein affects hair growth, with low levels delaying it and high levels increasing hair length in rodents.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Birth control pills can help reduce mild to moderate acne in women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Young women with PCOS and no other heart risk factors have normal heart function.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document suggests a young mother use effective contraception like the Copper-T IUD while considering her health and the need for STD prevention.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Finasteride negatively affects fish reproduction and gonadal development.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.